Abstract:Background & aims: The expression of HBsAg from integrated HBV DNA limits the achievement of functional cure for chronic hepatitis B. Thus, characterising the unique expression and secretion of HBsAg derived from integrated HBV DNA is of clinical significance. Methods: A total of 563 treatment-naive patients and 62 functionally cured patients were enrolled, and HBsAg and HBcAg immunohistochemistry of their liver biopsy tissues was conducted followed by semi-quantitative analysis. Then, based on stratified analysis of HBeAg-positive and -negative patients, long-read RNA sequencing analysis, as well as an in vitro HBV integration model, we explored the HBsAg secretion characteristics of integrated HBV DNA and underlying mechanisms. Results: In contrast to the significantly lower serum HBsAg levels, no significant decrease of intrahepatic HBsAg protein was observed in HBeAg-negative patients, as compared with HBeAg-positive patients. The results of long-read RNA sequencing of liver tissues from patients with chronic HBV infection and in vitro studies using integrated HBV DNA mimicking dslDNA plasmid revealed that, the lower HBsAg secretion efficiency seen in HBeAg-negative patients might be attributed to an increased proportion of preS1 mRNA derived from integrated HBV DNA instead of covalently closed circular DNA. The latter resulted in an increased L-HBsAg proportion and impaired HBsAg secretion. Enhancer 1 (EnhI) in integrated HBV DNA could retarget preS1 (SP1) and preS2 (SP2) promoters to disrupt their transcriptional activity balance. Conclusions: The secretion of HBsAg originating from integrated HBV DNA was impaired. Mechanistically, functional deficiency of core promoter leads to retargeting of EnhI and thus uneven activation of the SP1 over the SP2 promoter, resulting in an increase in the proportion of L-HBsAg. Impact and implications: Integrated hepatitis B virus (HBV) DNA can serve as an important reservoir for HBV surface antigen (HBsAg) expression, and this limits the achievement of a functional cure. This study revealed that secretion efficiency is lower for HBsAg derived from integrated HBV DNA than HBsAg derived from covalently closed circular DNA, as determined by the unique sequence features of integrated HBV DNA. This study can broaden our understanding of the role of HBV integration and shed new light on antiviral strategies to facilitate a functional cure. We believe our results are of great general interest to a broad audience, including patients and patient organisations, the medical community, academia, the life science industry and the public.

The Envelope Gene of Hepatitis B Virus is Implicated in Both Differential Virion Secretion and Genome Replication Capacities Between Genotype B and Genotype C Isolates.

Characterization of Contrasting Features Between Hepatitis B Virus Genotype A and Genotype D in Small Envelope Protein Expression and Surface Antigen Secretion.

Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity

Expression Level Of Small Envelope Protein In Addition To Sequence Divergence Inside Its Major Hydrophilic Region Contributes To More Efficient Surface Antigen Secretion By Hepatitis B Virus Subgenotype D2 Than Subgenotype A2

Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins

Cmv Promoter and the Mouse Albumin Promoter and Enhancer Triggered the Elevation of Hepatitis B Virus Envelope Polypeptides

Clinical isolates of hepatitis B virus genotype C have higher in vitro transmission efficiency than genotype B isolates

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Naturally Occurring 5' Pres1 Deletions Markedly Enhance Replication And Infectivity Of Hbv Genotype B And Genotype C

The Genotype (A to H) Dependent N-terminal Sequence of HBV Large Surface Protein Affects Viral Replication, Secretion and Infectivity

5' preS1 mutations to prevent large envelope protein expression from hepatitis B virus genotype A or genotype D markedly increase polymerase-envelope fusion protein

Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation

Functional Characterization of Hepatitis B Virus Core Promoter Mutants Revealed Transcriptional Interference among Co-Terminal Viral Mrnas.

A Single Amino Acid in the Reverse Transcriptase Domain of Hepatitis B Virus Affects Virus Replication Efficiency.

C-Terminal Substitution of HBV Core Proteins with Those from DHBV Reveals That Arginine-Rich 167RRRSQSPRR175 Domain Is Critical for HBV Replication

The Role of Hepatitis B Virus Surface Proteins in Regulating the Maturation and Secretion of Complete and Incomplete Virions.

Amino Acid Residues at Core Protein Dimer-Dimer Interface Modulate Multiple Steps of Hepatitis B Virus Replication and HBeAg Biogenesis

Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion

Functional Comparison of Two Full-length Genomes of Hepatitis B Virus Strains Isolated from Two Chronic Hepatitis B Patients

Extracellular Hepatitis B Virus RNAs Are Heterogeneous in Length and Circulate As Capsid-Antibody Complexes in Addition to Virions in Chronic Hepatitis B Patients

Replicative Efficiency and Pathogenicity of Hepatitis B Virus E‐minus Precore Variant